Controversy in clinical endocrinology: An optimal treatment for pediatric Graves' disease is radioiodine

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 797-800

  Rivkees, Scott A ^a   Dinauer, Catherine ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

ARTICLE; BONE MARROW DEPRESSION; CLINICAL PRACTICE; DRUG FATALITY; GENETIC DAMAGE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LEUKOPENIA; LIVER FAILURE; LONG TERM CARE; LOW DRUG DOSE; MYALGIA; NAUSEA; PAIN; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; REMISSION; RISK ASSESSMENT; SIDE EFFECT; THYROID CANCER; THYROTOXICOSIS; UNSPECIFIED SIDE EFFECT; URTICARIA; WHOLE BODY RADIATION; CHILD; EVALUATION; REVIEW;

CHILD; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; RISK ASSESSMENT;

EID: 33947536305     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1239     Document Type: Article

References (58)

1. Talbot NB, Sobel EH, McArthur JW, Crawford JD 1952 Functional endocrinology: from birth to adolescence. Cambridge, MA: Harvard University Press; 1-51
2. Wilkins L 1965 The diagnosis and treatment of endocrine disorders in children and adolescence. Springfield, IL: Charles Thomas; 141-150
3. Weetman AP 2003 Graves' disease 1835-2002. Horm Res 59(Suppl 1):114-118
4. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248
5. Chapman EM 1983 History of the discovery and early use of radioactive iodine. JAMA 250:2042-2044
6. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917
7. Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ 2003 Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab 16:1249-1255
8. Rivkees SA, Sklar C, Freemark M 1998 Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776
9. Hamburger JI 1985 Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 60:1019-1024
10. Glaser NS, Styne DM 1997 Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82:1719-1726
11. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW 1997 Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 7:755-760
12. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M 2000 Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85:3678-3682
13. Nicholas WC, Fischer RG, Stevenson RA, Bass JD 1995 Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism. South Med J 88:973-976
14. Greer MA, Kammer H, Bouma DJ 1977 Short-term antithyroid drug therapy for the thyrotoxicosis of Graves' disease. N Engl J Med 297:173-176
15. Weetman AP 2006 Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? Nat Clin Pract Endocrinol Metab 2:2-3
16. Zimmerman D, Lteif AN 1998 Thyrotoxicosis in children. Endocrinol Metab Clin North Am 27:109-126
17. Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH 2005 Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid 15:569-574
18. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A 1996 Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 120:1020-1024
19. Altman RP 1973 Total thyroidectomy for the treatment of Graves' disease in children. J Pediatr Surg 8:295-300
20. Terris DJ, Gourin CG, Chin E 2006 Minimally invasive thyroidectomy: basic and advanced techniques. Laryngoscope 116:350-356
21. Spinelli C, Bertocchini A, Antonelli A, Miccoli P 2004 Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or =16 years old. J Pediatr Surg 39:1500-1505
22. Harrison TS 1970 Thyroid surgery in historical perspective. J Med Liban 23:537-551
23. Read Jr CH, Tansey MJ, Menda Y 2004 A thirty-six year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 89:4229-4233
24. Levy WM, Schumacher OP, Gupta M 1988 Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med 55:373-382
25. Quimby EM, Feitelberg S, Gross W 1970 Radioactive nuclides in medicine and biology. Philadelphia: Lea and Febiger
26. Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA 2002 Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. J Pediatr 141:99-103
27. Rivkees SA, Cornelius EA 2003 Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 111:745-749
28. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H 1996 Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest 26:59-63
29. Becker DV, Hurley JR 1971 Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med 1:442-460
30. McDermott MT, Kidd GS, Dodson Jr LE, Hofeldt FD 1983 Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 75:353-359
31. Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA 2001 Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab 86:1865-1867
32. Moka D, Dietlein M, Schicha H 2002 Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med Mol Imaging 29(Suppl 2):S486-S491
33. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78
34. Krassas GE 2003 Ophthalmic complications in juvenile Graves' disease - clinical and therapeutic approaches. Pediatr Endocrinol Rev 1(Suppl 2):223-229
35. Tallstedt L, Lundell G 1997 Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective. Thyroid 7:241-245
36. Hedman I, Fjalling M, Lindberg S, Lundberg LM, Tisell LE 1985 An assessment of the risk of developing hyperparathyroidism and thyroid disorders subsequent to neck irradiation in middle-aged women. J Surg Oncol 29:78-81
37. 131I treatment for thyrotoxicosis. Acta Chir Scand 149:681-686
38. Boice Jr JD 2005 Radiation-induced thyroid cancer - what's new? J Natl Cancer Inst 97:703-705
39. Boice Jr JD 2006 Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA 295:1060-1062
40. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice Jr JD 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
41. Dolphin GW 1968 The risk of thyroid cancers following irradiation. Health Phys 15:219-228
42. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD 2005 Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365:2014-2023
43. Davis S, Kopecky KJ, Hamilton TE, Onstad L 2004 Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 292:2600-2613
44. 131I: a population-based cohort study in Sweden. Int J Cancer 106:580-587
45. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. J Clin Endocrinol Metab 38:976-998
46. Sheline GE, McCormack KR, Galante M 1962 Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. J Clin Endocrinol Metab 22:8-17
47. Boice Jr JD 1998 Radiation and thyroid cancer - what more can be learned? Acta Oncol 34:321-324
48. 131I for thyroid cancer. J Nucl Med 17:460-464
49. Schull WJ, Otake M, Neel JV 1981 Genetic effects of the atomic bombs: a reappraisal. Science 213:1220-1227
50. Robertson JS, Gorman CA 1976 Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med 17:826-835
51. Saenger EL, Thoma GE, Tompkins EA 1968 Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA 205:855-862
52. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris 3rd BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-Up Study Group. JAMA 280:347-355
53. 131I treatment of hyperthyroidism. Int J Cancer 50:886-890
54. Toohey RE, Stabin MG, Watson EE 2000 The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics 20:533-546
55. Toohey RE, Stabin MG 1996 Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99-1064, 1999. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium, Gatlinburg, TN, 1996, pp 532-551
56. Committee on Health Effects of Exposure to Low Levels of Ionizing Radiations (Beir VII) NRC 1998 Health effects of exposure to low levels of ionizing radiations: time for reassessment? Washington, DC: National Academy of Science
57. Hendee WR 1992 Estimation of radiation risks. BEIR V and its significance for medicine. JAMA 268:620-624
58. Committee on the Biological Effects of Ionizing Radiation (BEIR V) NRC 1990 Health effects of exposure to low levels of ionizing radiation: BEIR V. Washington DC: National Academy Press